Search clinical trials for: Everolimus-Eluting Stent (PROMUS ELEMENT)

Total 581 results

San Giuseppe Moscati Hospital

Completed

Everolimus Stent in Myocardial Infarction (RaCES-MI)

Acute Myocardial Infarction

Italy
Boston Scientific Corporation

Completed

PROMUS Element Japan Small Vessel Trial

Coronary Artery Disease | Atherosclerosis

Japan
Abbott Medical Devices

Completed

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study (XV CHINA SAS)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angioplasty

United States
Hospital Universitari Vall d'Hebron Research Institute
B.Braun Surgical SA

Completed

Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up

Coronary Artery Disease

Spain
Henan Institute of Cardiovascular Epidemiology

Recruiting

DCB Under the Guidance of OCT in STEMI

Acute ST-segment Elevation Myocardial Infarction

China
University Hospital Inselspital, Berne
University of Bern; Biotronik AG

Completed

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Myocardial Infarction | Coronary Artery Disease | Angina Pectoris

Switzerland
Medstar Health Research Institute

Recruiting

IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact (IMPROVE)

Atherosclerosis

United States, Sweden, Germany, Israel, Italy, United Kingdom, Greece
Fatebenefratelli and Ophthalmic Hospital

Completed

Drug Eluting Balloon Efficacy for Small Coronary Vessel Disease Treatment (PICCOLETO II)

Cardiovascular Diseases
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
The Hospital District of Satakunta

Unknown

Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome (TIDES-ACS)

Myocardial Infarction | Atherosclerosis | Percutaneous Coronary Intervention

Finland
Boston Scientific Corporation

Completed

A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) (PLATINUM QCA)

Coronary Artery Disease | Atherosclerosis

Australia, New Zealand, Malaysia, Singapore
Abbott Medical Devices

Terminated

SPIRIT Small Vessel Registry (SPIRIT SV)

Myocardial Ischemia | Coronary Artery Disease | Atherosclerosis

United States
A.O. Ospedale Papa Giovanni XXIII
Light Lab Imaging, Inc.

Completed

Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial (OCTAVIA)

Acute Myocardial Infarction
University of Saskatchewan

Unknown

Soluble Receptors for Advanced Glycation End-Products and PCI

Acute Coronary Syndrome

Canada
Seoul National University Hospital
Boston Scientific Korea Co. Ltd; Dio; Terumo Corporation; Abbott

Unknown

Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)

Acute Coronary Syndrome

Korea, Republic of
Chang Gung Memorial Hospital

Not yet recruiting

Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation Lesions

Coronary Artery Disease

Taiwan
Chonnam National University Hospital

Completed

Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease

Korea, Republic of
Deutsches Herzzentrum Muenchen

Unknown

A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction (ISAR-Absorb MI)

Myocardial Infarction | Cardiovascular Disease | Thrombus | Primary Angioplasty

Germany
Deutsches Herzzentrum Muenchen

Unknown

Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents (ISAR-TEST6)

Coronary Heart Disease

Germany
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)

Percutaneous Coronary Intervention | Drug-Eluting Stents | Tomography, Optical Coherence

China
Boston Scientific Corporation
Labcoat, Ltd.

Completed

The Optical Coherence Tomography Drug Eluting Stent Investigation (OCTDESI)

Coronary Artery Disease

Italy
Yonsei University

Completed

Intravascular ULTrasound Guided Versus Conventional Angiography Guided Strategy to Deploy Zotarolimus and Everolimus Eluting Third Generation Stents in the Long Coronary Artery Lesions: ULTRA-ZET Trial

Coronary Artery Disease

Korea, Republic of
Russian Academy of Medical Sciences
Medtronic

Unknown

Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI (ZES for STEMI)

ST Elevation Myocardial Infarction, Multivessel Coronary Artery Disease

Russian Federation
Euro CTO Club
NHS Research and Development; Biosensors International; Asahi Intecc Co., Ltd.

Completed

A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions (EuroCTO)

Coronary Occlusion | Dyspnea | Chronic Stable Angina

United Kingdom, Spain, France, Germany, Italy, Latvia
Medtronic Bakken Research Center

Completed

E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary Stent (eFive)

Coronary Artery Disease
Abbott Medical Devices

Completed

EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease (EXecutive)

Coronary Artery Disease | Coronary Disease | Coronary Artery Stenosis | Coronary Artery Restenosis

Italy
Seoul National University Hospital

Unknown

Comparison of the Efficacy of Paclitaxel-releasing Balloon Catheter System Versus the Everolimus-Eluting Stent System for Treatment of In-Stent Restenosis Lesions - Harmonizing Optimal Strategy for Treatment of In-Stent Restenosis Lesions (The HOST-ISR Trial) -

In-stent Restenosis Lesion

Korea, Republic of
Nanfang Hospital of Southern Medical University

Recruiting

Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis

Ischemic Stroke | Vertebral Artery Stenosis

China
Medtronic Vascular

Completed

RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia (R-A)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Coronary Stenosis

India
Cook Group Incorporated

Completed

V-Flex Plus PTX Drug Eluting Coronary Stent (ELUTES III)

Coronary Artery Disease

United States
Spanish Society of Cardiology

Unknown

Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques

Coronary Artery Disease

Spain
Catholic University of the Sacred Heart

Completed

A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

Saphenous Vein Graft Disease
Yonsei University

Completed

Comparison of Biodegradable Stents: Orsiro and BioMatrix

Percutaneous Coronary Intervention | All-comer

Korea, Republic of
Boston Scientific Corporation

Completed

The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Coronary Artery Disease

United States, Spain, Denmark, Belgium, New Zealand, Australia, France, Italy, Canada, Singapore, Netherlands, Japan, Austria, Finland, Poland, Latvia
First Affiliated Hospital of Zhejiang University

Recruiting

Eluvia DES for the Patients With Femoropopliteal Artery Lesions.

Vascular Diseases | Stent Complication

China
Biotronik France

Unknown

BIOTRONIK - BIOFLOW-III Registry French Satellite

Coronary Artery Diseases

France
Cook Group Incorporated

Completed

In Stent ELUTES Study (ELUTES II)

Coronary Artery Disease

United States
KCRI
Vascular Concepts Limited

Completed

A Clinical Evaluation of the ProNOVA XR Polymer Free Drug Eluting Coronary Stent System (EURONOVA)

Myocardial Ischemia

Poland
Broncus Technologies

Completed

Exhale (R) Stent for Emphysema

Emphysema

Germany, Australia, Brazil
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial (AIDA)

Myocardial Infarction | Coronary Artery Disease

Netherlands
Yonsei University

Unknown

Comparison of the PrimAry Long Versus Short Coverage With Drug-Eluting Stents for Long FemoRopopliteal Artery DiseasE (PARADE II): Investigator-initiated Clinical Study

Femoropopliteal Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Terminated

Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis (RESTORE)

Coronary Restenosis

Korea, Republic of
Yonsei University

Withdrawn

Comparison of the 3-month Strut Coverage After Coronary Stenting by Optical Coherence Tomography; Cilotax and DESyne

Patients in the Treatment of Subjects With All-comer Who Are to Undergo PCI
Centro de estudios en Cardiologia Intervencionista

Completed

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents (ORAR III)

Coronary Heart Disease | Coronary Restenosis

Argentina
Shigeru Saito
NPO International TRI Network

Terminated

Nobori And Uncoated Stent In Coronary Attack

Acute Myocardial Infarction

Japan
San Giuseppe Moscati Hospital

Completed

Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

ST Elevation Acute Myocardial Infarction

Italy
European Hospital

Completed

Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease (RENAL-DES)

Chronic Kidney Disease | Multivessel Coronary Artery Disease

Italy
Seoul National University Hospital
Medtronic

Unknown

Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis (HOST-ONYX)

Myocardial Infarction | Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome

Korea, Republic of
Cordis Corporation

Completed

Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease (ACHILLES)

Peripheral Arterial Diseases

Germany
Shanghai Jiao Tong University School of Medicine

Completed

Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions (RESOLUTE-DM)

Coronary Artery Disease | Diabetes

China

Search clinical trials for: Everolimus-Eluting Stent (PROMUS ELEMENT)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations